Year |
Citation |
Score |
2020 |
Glubb DM, Thompson DJ, Aben KK, Alsulimani A, Amant F, Annibali D, Attia J, Barricarte A, Beckmann MW, Berchuck A, Bermisheva M, Bernardini MQ, Bischof K, Bjørge L, Bodelon C, et al. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33144283 DOI: 10.1158/1055-9965.EPI-20-0739 |
0.321 |
|
2020 |
Zhang YD, Hurson AN, Zhang H, Choudhury PP, Easton DF, Milne RL, Simard J, Hall P, Michailidou K, Dennis J, Schmidt MK, Chang-Claude J, Gharahkhani P, Whiteman D, Campbell PT, ... ... Thompson DJ, et al. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nature Communications. 11: 3353. PMID 32620889 DOI: 10.1038/S41467-020-16483-3 |
0.355 |
|
2020 |
Bafligil C, Thompson DJ, Lophatananon A, Smith MJ, Ryan NA, Naqvi A, Evans DG, Crosbie EJ. Association between genetic polymorphisms and endometrial cancer risk: a systematic review. Journal of Medical Genetics. PMID 32066633 DOI: 10.1136/jmedgenet-2019-106529 |
0.331 |
|
2019 |
Vachon CM, Scott CG, Tamimi RM, Thompson DJ, Fasching PA, Stone J, Southey MC, Winham S, Lindström S, Lilyquist J, Giles GG, Milne RL, MacInnis RJ, Baglietto L, Li J, et al. Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk. Breast Cancer Research : Bcr. 21: 68. PMID 31118087 DOI: 10.1186/S13058-019-1138-8 |
0.328 |
|
2019 |
O'Mara TA, Glubb DM, Kho PF, Thompson DJ, Spurdle AB. Genome-wide association studies of endometrial cancer: Latest developments and future directions. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31040137 DOI: 10.1158/1055-9965.EPI-18-1031 |
0.325 |
|
2019 |
Kho PF, Glubb DM, Thompson DJ, Spurdle AB, O'Mara TA. Assessing the Role of Selenium in Endometrial Cancer Risk: A Mendelian Randomization Study. Frontiers in Oncology. 9: 182. PMID 30972295 DOI: 10.3389/fonc.2019.00182 |
0.31 |
|
2018 |
Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, ... ... Thompson DJ, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics. PMID 30554720 DOI: 10.1016/J.Ajhg.2018.11.002 |
0.371 |
|
2018 |
O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, ... ... Thompson DJ, et al. Identification of nine new susceptibility loci for endometrial cancer. Nature Communications. 9: 3166. PMID 30093612 DOI: 10.1038/S41467-018-05427-7 |
0.32 |
|
2017 |
Day FR, Thompson DJ, Helgason H, Chasman DI, Finucane H, Sulem P, Ruth KS, Whalen S, Sarkar AK, Albrecht E, Altmaier E, Amini M, Barbieri CM, Boutin T, Campbell A, et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nature Genetics. PMID 28436984 DOI: 10.1038/Ng.3841 |
0.32 |
|
2016 |
Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. PMID 27432226 DOI: 10.1158/2159-8290.Cd-15-1227 |
0.337 |
|
2016 |
Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H, Aittomäki K, Ambrosone C, Andrulis IL, Anton-Culver H, Arndt V, ... ... Thompson D, et al. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nature Communications. 7: 11375. PMID 27117709 DOI: 10.1038/Ncomms11375 |
0.354 |
|
2015 |
Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, Sulem P, Bulik-Sullivan B, Esko T, Johnson AD, Elks CE, Franceschini N, He C, et al. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nature Genetics. PMID 26414677 DOI: 10.1097/01.Ogx.0000473766.71624.99 |
0.355 |
|
2015 |
Lindström S, Thompson DJ, Paterson AD, Li J, Gierach GL, Scott C, Stone J, Douglas JA, Dos-Santos-Silva I, Fernandez-Navarro P, Verghase J, Smith P, Brown J, Luben R, Wareham NJ, et al. Corrigendum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk. Nature Communications. 6: 8358. PMID 26349435 DOI: 10.1038/Ncomms9358 |
0.349 |
|
2015 |
O'Mara TA, Glubb DM, Painter JN, Cheng T, Dennis J, Attia J, Holliday EG, McEvoy M, Scott RJ, Ashton K, Proietto T, Otton G, Shah M, Ahmed S, ... ... Thompson DJ, et al. Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. Endocrine-Related Cancer. 22: 851-61. PMID 26330482 DOI: 10.1530/Erc-15-0319 |
0.35 |
|
2015 |
Darabi H, McCue K, Beesley J, Michailidou K, Nord S, Kar S, Humphreys K, Thompson D, Ghoussaini M, Bolla MK, Dennis J, Wang Q, Canisius S, Scott CG, Apicella C, et al. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. American Journal of Human Genetics. 97: 22-34. PMID 26073781 DOI: 10.1016/J.Ajhg.2015.05.002 |
0.335 |
|
2015 |
Stone J, Thompson DJ, Dos Santos Silva I, Scott C, Tamimi RM, Lindstrom S, Kraft P, Hazra A, Li J, Eriksson L, Czene K, Hall P, Jensen M, Cunningham J, Olson JE, et al. Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures. Cancer Research. 75: 2457-67. PMID 25862352 DOI: 10.1158/0008-5472.Can-14-2012 |
0.356 |
|
2015 |
Glubb DM, Maranian MJ, Michailidou K, Pooley KA, Meyer KB, Kar S, Carlebur S, O'Reilly M, Betts JA, Hillman KM, Kaufmann S, Beesley J, Canisius S, Hopper JL, Southey MC, ... ... Thompson DJ, et al. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. American Journal of Human Genetics. 96: 5-20. PMID 25529635 DOI: 10.1016/J.Ajhg.2014.11.009 |
0.325 |
|
2014 |
Brand JS, Humphreys K, Thompson DJ, Li J, Eriksson M, Hall P, Czene K. Volumetric mammographic density: heritability and association with breast cancer susceptibility loci. Journal of the National Cancer Institute. 106. PMID 25376863 DOI: 10.1093/jnci/dju334 |
0.31 |
|
2014 |
Lindström S, Thompson DJ, Paterson AD, Li J, Gierach GL, Scott C, Stone J, Douglas JA, dos-Santos-Silva I, Fernandez-Navarro P, Verghase J, Smith P, Brown J, Luben R, Wareham NJ, et al. Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk. Nature Communications. 5: 5303. PMID 25342443 DOI: 10.1038/Ncomms6303 |
0.342 |
|
2014 |
Killick E, Tymrakiewicz M, Cieza-Borrella C, Smith P, Thompson DJ, Pooley KA, Easton DF, Bancroft E, Page E, Leongamornlert D, Kote-Jarai Z, Eeles RA. Telomere length shows no association with BRCA1 and BRCA2 mutation status. Plos One. 9: e86659. PMID 24489760 DOI: 10.1371/journal.pone.0086659 |
0.304 |
|
2013 |
Pooley KA, Bojesen SE, Weischer M, Nielsen SF, Thompson D, Amin Al Olama A, Michailidou K, Tyrer JP, Benlloch S, Brown J, Audley T, Luben R, Khaw KT, Neal DE, Hamdy FC, et al. A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Human Molecular Genetics. 22: 5056-64. PMID 23900074 DOI: 10.1093/Hmg/Ddt355 |
0.305 |
|
2012 |
Varghese JS, Smith PL, Folkerd E, Brown J, Leyland J, Audley T, Warren RM, Dowsett M, Easton DF, Thompson DJ. The heritability of mammographic breast density and circulating sex-hormone levels: two independent breast cancer risk factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 2167-75. PMID 23074290 DOI: 10.1158/1055-9965.EPI-12-0789 |
0.34 |
|
2012 |
Li Y, Low HQ, Foo JN, Darabi H, EinarsdÏŒttir K, Humphreys K, Spurdle A, Easton DF, Thompson DJ, Dunning AM, Pharoah PD, Czene K, Chia KS, Hall P, et al. Genetic variants in ER cofactor genes and endometrial cancer risk. Plos One. 7: e42445. PMID 22876322 DOI: 10.1371/journal.pone.0042445 |
0.313 |
|
2012 |
Prescott J, Thompson DJ, Kraft P, Chanock SJ, Audley T, Brown J, Leyland J, Folkerd E, Doody D, Hankinson SE, Hunter DJ, Jacobs KB, Dowsett M, Cox DG, Easton DF, et al. Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women. Plos One. 7: e37815. PMID 22675492 DOI: 10.1371/Journal.Pone.0037815 |
0.35 |
|
2012 |
Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernández-Navarro P, ... ... Thompson DJ, et al. Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1156-66. PMID 22454379 DOI: 10.1158/1055-9965.Epi-12-0066 |
0.362 |
|
2012 |
Varghese JS, Thompson DJ, Michailidou K, Lindström S, Turnbull C, Brown J, Leyland J, Warren RM, Luben RN, Loos RJ, Wareham NJ, Rommens J, Paterson AD, Martin LJ, Vachon CM, et al. Mammographic breast density and breast cancer: evidence of a shared genetic basis. Cancer Research. 72: 1478-84. PMID 22266113 DOI: 10.1158/0008-5472.CAN-11-3295 |
0.392 |
|
2011 |
Healey CS, Ahmed S, O'Mara TA, Ferguson K, Lambrechts D, Garcia-Dios DA, Vergote I, Amant F, Howarth K, Gorman M, Hodgson S, ... ... Thompson DJ, et al. Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study. Carcinogenesis. 32: 1862-6. PMID 21965274 DOI: 10.1093/Carcin/Bgr214 |
0.398 |
|
2011 |
O'Mara TA, Ferguson K, Fahey P, Marquart L, Yang HP, Lissowska J, Chanock S, Garcia-Closas M, Thompson DJ, Healey CS, Dunning AM, Easton DF, Webb PM, Spurdle AB, Young J, et al. CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk Twin Research and Human Genetics. 14: 328-332. PMID 21787115 DOI: 10.1375/twin.14.4.328 |
0.324 |
|
2011 |
Spurdle AB, Thompson DJ, Ahmed S, Ferguson K, Healey CS, O'Mara T, Walker LC, Montgomery SB, Dermitzakis ET, Fahey P, Montgomery GW, Webb PM, Fasching PA, Beckmann MW, et al. Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nature Genetics. 43: 451-4. PMID 21499250 DOI: 10.1038/Ng.812 |
0.33 |
|
2011 |
Lindström S, Vachon CM, Li J, Varghese J, Thompson D, Warren R, Brown J, Leyland J, Audley T, Wareham NJ, Loos RJ, Paterson AD, Rommens J, Waggott D, Martin LJ, et al. Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nature Genetics. 43: 185-7. PMID 21278746 DOI: 10.1038/Ng.760 |
0.374 |
|
2010 |
Ding J, Warren R, Girling A, Thompson D, Easton D. Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. The Breast Journal. 16: 279-89. PMID 20408823 DOI: 10.1111/j.1524-4741.2010.00907.x |
0.315 |
|
2010 |
Mavaddat N, Pharoah PD, Blows F, Driver KE, Provenzano E, Thompson D, Macinnis RJ, Shah M, Easton DF, Antoniou AC. Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. Breast Cancer Research : Bcr. 12: R10. PMID 20146796 DOI: 10.1186/bcr2476 |
0.369 |
|
2009 |
Thompson DJ, Leach MO, Kwan-Lim G, Gayther SA, Ramus SJ, Warsi I, Lennard F, Khazen M, Bryant E, Reed S, Boggis CR, Evans DG, Eeles RA, Easton DF, Warren RM, et al. Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study. Breast Cancer Research : Bcr. 11: R80. PMID 19903338 DOI: 10.1186/bcr2447 |
0.322 |
|
2009 |
Gilbert FJ, Warren RM, Kwan-Lim G, Thompson DJ, Eeles RA, Evans DG, Leach MO. Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features. Radiology. 252: 358-68. PMID 19703879 DOI: 10.1148/radiol.2522081032 |
0.324 |
|
2009 |
Evans DG, Lennard F, Pointon LJ, Ramus SJ, Gayther SA, Sodha N, Kwan-Lim GE, Leach MO, Warren R, Thompson D, Easton DF, Eeles R. Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2123-31. PMID 19567506 DOI: 10.1158/1055-9965.EPI-09-0138 |
0.302 |
|
2008 |
Thompson DJ, Healey CS, Baynes C, Kalmyrzaev B, Ahmed S, Dowsett M, Folkerd E, Luben RN, Cox D, Ballinger D, Pharoah PD, Ponder BA, Dunning AM, Easton DF. Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3490-8. PMID 19064566 DOI: 10.1158/1055-9965.Epi-08-0734 |
0.302 |
|
2008 |
Ding J, Warren R, Warsi I, Day N, Thompson D, Brady M, Tromans C, Highnam R, Easton D. Evaluating the effectiveness of using standard mammogram form to predict breast cancer risk: case-control study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1074-81. PMID 18483328 DOI: 10.1158/1055-9965.Epi-07-2634 |
0.352 |
|
2007 |
Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 447: 1087-93. PMID 17529967 DOI: 10.1038/Nature05887 |
0.35 |
|
2007 |
Baynes C, Healey CS, Pooley KA, Scollen S, Luben RN, Thompson DJ, Pharoah PD, Easton DF, Ponder BA, Dunning AM. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. Breast Cancer Research : Bcr. 9: R27. PMID 17428325 DOI: 10.1186/Bcr1669 |
0.352 |
|
2007 |
Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nature Genetics. 39: 165-7. PMID 17200668 DOI: 10.1038/ng1959 |
0.322 |
|
2006 |
Thompson D, Seal S, Schutte M, McGuffog L, Barfoot R, Renwick A, Eeles R, Sodha N, Houlston R, Shanley S, Klijn J, Wasielewski M, Chang-Claude J, Futreal PA, Weber BL, et al. A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 2542-5. PMID 17164383 DOI: 10.1158/1055-9965.Epi-06-0687 |
0.364 |
|
2006 |
Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Easton DF, et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nature Genetics. 38: 873-5. PMID 16832357 DOI: 10.1038/ng1837 |
0.343 |
|
2006 |
Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA, Luccarini C, Munday H, Perkins B, Smith P, Pharoah PD, Wareham NJ, Easton DF, Ponder BA, Dunning AM. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Human Molecular Genetics. 15: 1-10. PMID 16306136 DOI: 10.1093/Hmg/Ddi398 |
0.355 |
|
2005 |
Thompson D, Kriebel D, Quinn MM, Wegman DH, Eisen EA. Occupational exposure to metalworking fluids and risk of breast cancer among female autoworkers. American Journal of Industrial Medicine. 47: 153-60. PMID 15662639 DOI: 10.1002/Ajim.20132 |
0.442 |
|
2005 |
Thompson D, Easton D. The genetic epidemiology of breast cancer genes. Journal of Mammary Gland Biology and Neoplasia. 9: 221-36. PMID 15557796 DOI: 10.1023/B:JOMG.0000048770.90334.3b |
0.368 |
|
2004 |
Sinilnikova OM, Ginolhac SM, Magnard C, Léoné M, Anczukow O, Hughes D, Moreau K, Thompson D, Coutanson C, Hall J, Romestaing P, Gérard JP, Bonadona V, Lasset C, Goldgar DE, et al. Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility. Carcinogenesis. 25: 2417-24. PMID 15333468 DOI: 10.1093/carcin/bgh273 |
0.375 |
|
2002 |
Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, ... ... Thompson D, et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nature Genetics. 31: 55-9. PMID 11967536 DOI: 10.1038/Ng879 |
0.351 |
|
2002 |
Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, Seal S, Barfoot R, Kroeze-Jansema K, Teare D, Rahman N, Renard H, Mann G, Hopper JL, Buys SS, Andrulis IL, et al. Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proceedings of the National Academy of Sciences of the United States of America. 99: 827-31. PMID 11792833 DOI: 10.1073/Pnas.012584499 |
0.302 |
|
Show low-probability matches. |